Harris A. Gelbard

Harris A. Gelbard

Auto-generated profile, based on publicly available information

Harris A. Gelbard

University of Rochester Medical Center

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in BioTechniques
Verified
Journal Article
Open access
SPSeth W. Perry
Seth W. Perry
JNJohn P. Norman
John P. Norman
JBJustin Barbieri
Justin Barbieri
EBEdward B. Brown
Edward B. Brown
HGHarris A. Gelbard
Harris A. Gelbard
Fluorescent probes for monitoring mitochondrial membrane potential are frequently used for assessing mitochondrial function, particularly in the context of cell fate determination in biological and...

5 August 2005 in Science
Verified
Journal Article
Closed access
PDF file
RMRoy Mukamel
Roy Mukamel
HGHagar Gelbard
Hagar Gelbard
AAAmos Arieli
Amos Arieli
UHUri Hasson
Uri Hasson
IFItzhak Fried
Itzhak Fried
RMRafael Malach
Rafael Malach
Functional magnetic resonance imaging (fMRI) is an important tool for investigating human brain function, but the relationship between the hemodynamically based fMRI signals in the human brain and the underlying neuronal activity is unclear. We recorded single unit activity and local field potentials in auditory cortex of two neurosurgical patients and compared them with the fMRI signals of 11 healthy subjects during presentation of an identical movie segment. The predicted fMRI signals derived from single units and the measured fMRI signals from auditory cortex showed a highly significant correlation ( r = 0.75, P < 10 –47 ). Thus, fMRI signals can provide a reliable measure of the firing rate of human cortical neurons.

1 December 1992 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PGP Genis
P Genis
MJM Jett
M Jett
EBE W Bernton
E W Bernton
TBT Boyle
T Boyle
HGH A Gelbard
H A Gelbard
DVD J Volsky
D J Volsky
Human immunodeficiency virus (HIV) infection of brain macrophages and astroglial proliferation are central features of HIV-induced central nervous system (CNS) disorders. These observations suggest that glial cellular interactions participate in disease. In an experimental system to examine this process, we found that cocultures of HIV-infected monocytes and astroglia release high levels of cytokines and arachidonate metabolites leading to neuronotoxicity. HIV-1ADA-infected monocytes cocultured with human glia (astrocytoma, neuroglia, and primary human astrocytes) synthesized tumor necrosis factor (TNF-alpha) and interleukin 1 beta (IL-1 beta) as assayed by coupled reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay, and biological activity. The cytokine induction was selective, cell specific, and associated with induction of arachidonic acid metabolites. TNF-beta, IL-1 alpha, IL-6, interferon alpha (IFN-alpha), and IFN-gamma were not produced. Leukotriene B4, leukotriene D4, lipoxin A4, and platelet-activating factor were detected in large amounts after high-performance liquid chromatography separation and correlated with cytokine activity. Specific inhibitors of the arachidonic cascade markedly diminished the cytokine response suggesting regulatory relationships between these factors. Cocultures of HIV-infected monocytes and neuroblastoma or endothelial cells, or HIV-infected monocyte fluids, sucrose gradient-concentrated viral particles, and paraformaldehyde-fixed or freeze-thawed HIV-infected monocytes placed onto astroglia failed to induce cytokines and neuronotoxins. This demonstrated that viable monocyte-astroglia interactions were required for the cell reactions. The addition of actinomycin D or cycloheximide to the HIV-infected monocytes before coculture reduced, > 2.5-fold, the levels of TNF-alpha. These results, taken together, suggest that the neuronotoxicity associated with HIV central nervous system disorders is mediated, in part, through cytokines and arachidonic acid metabolites, produced during cell-to-cell interactions between HIV-infected brain macrophages and astrocytes.

1 March 1999 in Brain Research
Verified
Journal Article
Open access
ABA.I Brooks
A.I Brooks
CCC.A Chadwick
C.A Chadwick
HGH.A Gelbard
H.A Gelbard
DCD.A Cory-Slechta
D.A Cory-Slechta
HFH.J Federoff
H.J Federoff
The herbicide paraquat, bearing structural similarity to the known dopaminergic neurotoxicant MPTP, has been suggested as a potential etiologic factor in Parkinson's disease. Consideration of paraquat as a candidate neurotoxicant requires demonstration that systemic delivery produces substantia nigra dopaminergic neuron loss and the attendant neurobehavioral syndrome reflecting depletion of dopamine terminals within the striatum. To address these issues paraquat was administered systemically into adult C57 bl/6 mice, ambulatory behavior monitored, substantia nigra dopamine neuron number and striatal dopamine terminal density quantified. The data indicate that paraquat like MPTP elicits a dose-dependent decrease in substantia nigra dopaminergic neurons assessed by a Fluoro-gold prelabeling method, a decline in striatal dopamine nerve terminal density assessed by measurement of tyrosine hydroxylase immunoreactivity; and neurobehavioral syndrome characterized by reduced ambulatory activity. Taken together, these data suggest that systemically absorbed paraquat crosses the blood-brain barrier to cause destruction of dopamine neurons in the substantia nigra, consequent reduction of dopaminergic innervation of the striatum and a neurobehavioral syndrome similar to the well characterized and bona fide dopaminergic toxin MPTP.

12 May 2006 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
YGYulia Golland
Yulia Golland
SBShlomo Bentin
Shlomo Bentin
HGHagar Gelbard
Hagar Gelbard
YBYoav Benjamini
Yoav Benjamini
RHRuth Heller
Ruth Heller
RMRafael Malach
Rafael Malach
When exposing subjects to a continuous segment of an audiovisual movie, a large expanse of human cortex, especially in the posterior half of the cerebral cortex, shows stimulus-driven activity. However, embedded within this widespread activity, there are cortical regions whose activity is dissociated from the external stimulation. These regions are intercorrelated among themselves, forming a functional network, which largely overlaps with cortical areas previously shown to be deactivated by task-oriented paradigms. Moreover, the network of areas whose neuronal dynamics are associated with external inputs and the network of areas that appears to be intrinsically driven complement each other, providing coverage of most of the posterior cortex. Thus, we propose that naturalistic stimuli reveal a fundamental neuroanatomical partition of the human posterior cortex into 2 global networks: an “extrinsic” system, comprising areas associated with the processing of external inputs, and an “intrinsic” system, largely overlapping with the task-negative, default-mode network, comprising areas associated with—as yet not fully understood—intrinsically oriented functions.

1 June 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SFSteven M. Fine
Steven M. Fine
RARobert A. Angel
Robert A. Angel
SPSeth W. Perry
Seth W. Perry
LELeon G. Epstein
Leon G. Epstein
JRJeffrey D. Rothstein
Jeffrey D. Rothstein
HGHarris A. Gelbard
Harris A. Gelbard
Human immunodeficiency virus (HIV) infection is commonly associated with neurological disease that occurs in the apparent absence of extensive infection of brain cells by HIV, suggesting that indirect mechanisms account for neuropathogenesis in the CNS, perhaps including changes in the normal neuroprotective functions of astrocytes. To test this hypothesis, we examined the effect of the pro-inflammatory cytokine, tumor necrosis factor α (TNFα), produced by HIV-1-infected macrophages and microglia, on glutamate transport by primary human fetal astrocytes (PHFAs). A dose-dependent inhibition of high affinity glutamate uptake sites was observed 12–24 h after addition of exogenous recombinant human TNFα to PHFAs. This effect was specific since it was blocked by a neutralizing monoclonal antibody directed against TNFα. Furthermore, the inhibitory effect was reproduced by a monoclonal antibody that is an agonist at the 55-kDa TNF receptor. These results suggest that the neurotoxic effects of TNFα may be due in part to its ability to inhibit glutamate uptake by astrocytes, which in turn may result in excitotoxic concentrations of glutamate in synapses.